Live Quote · NASDAQABCLHealthcare· Biotechnology

AbCellera Biologics Inc.

$6.46▲ 4.95%(+$0.30)
TickerSpark Score
71/100
▌ Solid
40
Valuation
40
Profitability
90
Growth
84
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ABCL research report →

52-Week Range65% of range
Low
$2.75
Current
$6.46
High
$8.44
Company Overviewwww.abcellera.com

About the company

AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs.

CEO
Carl Hansen
IPO
2020
Employees
562
HQ
Vancouver, BC, CA

Price Chart

+65.90% · this period
$8.12$5.45$2.78Jul 17Jan 15Jul 17

Get TickerSpark's AI analysis on ABCL

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in